Cyclic peptides and use as medicines

The present invention provides a compound of formula I; or a pharmaceutically acceptable salt thereof, wherein R1, R2, R3, R4, R5, and A-B are as defined herein, which are non-immunosuppressive, cyclophilin-binding, mPTP blockers and are therefore useful for the prevention or treatment of diseases o...

Full description

Saved in:
Bibliographic Details
Main Authors Tjandra Meiliana, Mergo Wosenu, Sweeney Zachary Kevin, Karur Subramanian, Yifru Aregahegn, Li Xiaolin, Lu Peichao, Rivkin Alexey, Weiss Andrew, Fu Jiping
Format Patent
LanguageEnglish
Published 14.02.2017
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The present invention provides a compound of formula I; or a pharmaceutically acceptable salt thereof, wherein R1, R2, R3, R4, R5, and A-B are as defined herein, which are non-immunosuppressive, cyclophilin-binding, mPTP blockers and are therefore useful for the prevention or treatment of diseases or disorders such as HCV infection, stroke, multiple sclerosis, HBV infection, HPV infection, asthma, cancer, muscular dystrophy, sepsis, ischemia/reperfusion injury, and heart failure.
Bibliography:Application Number: US201514717872